Entrada Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -94.62M-6.64M65.60M
Depreciation and Depletion 0.33M1.12M1.90M2.84M3.80M
Share-based Compensation 0.33M2.53M9.89M13.11M17.91M
Gains from Investment Securities 0.54M0.33M4.34M77.58M4.62M
Cash from Operations -25.57M-50.86M-93.79M139.80M-41.56M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.15M5.78M10.02M
Depreciation & Amortization (CF) 0.33M1.12M1.90M2.84M3.80M
Change in Working Capital
Change in Account Payables 0.63M-0.71M5.29M-2.81M0.99M
Change in Accured Expenses 0.58M3.96M1.76M3.81M1.71M
Change in Taxes 4.02M-3.36M
Other Working Capital Changes 0.31M6.73M14.02M139.98M-119.81M
Investing Activities
Capital Expenditures 2.32M4.58M2.89M5.61M3.16M
Change in Acquisitions & Divestments 76.21M274.43M413.08M
Cash from Investing Activities -2.32M-4.58M-148.65M-138.40M-27.80M
Financing Activities
Cash from Financing Activities 50.09M307.46M0.48M21.04M102.96M
Additional items
Change in Cash 22.20M252.02M-241.96M22.45M33.61M
Free Cash Flow -27.89M-55.44M-96.67M134.19M-44.72M
Net Cash Flow 22.20M252.02M-241.96M22.45M33.61M